Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Media News.
Press releases published on April 23, 2025
Palvella Therapeutics Announces Abstract Highlighting the Estimated Diagnosed Prevalence and Annual Incidence of Lymphatic Malformations in the U.S. Accepted for Poster Presentation at the 82nd Annual Meeting of the Society for Investigative Dermatology
GlobeNewswire
·
April 23, 2025
Quantitative analysis of medical claims indicates an estimated 44,553 to 92,967 diagnosed U.S. patients with lymphatic malformations (LMs) with cutaneous involvement Estimates of annual incidence of LMs with cutaneous involvement to be highlighted in the …
Jayud Global Logistics Files 2024 Annual Report on Form 20-F
GlobeNewswire
·
April 23, 2025
SHENZHEN, China, April 23, 2025 (GLOBE NEWSWIRE) -- Jayud Global Logistics Limited (NASDAQ: JYD) ("Jayud" or the "Company"), a leading end-to-end supply chain solution provider based in Shenzhen specializing in cross-border logistics, today announced that …
Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses
GlobeNewswire
·
April 23, 2025
SAN CARLOS, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with …
Raymond James Financial Reports Fiscal Second Quarter of 2025 Results
GlobeNewswire
·
April 23, 2025
ST. PETERSBURG, Fla., April 23, 2025 (GLOBE NEWSWIRE) -- Quarterly net revenues of $3.40 billion, up 9% over the prior year’s fiscal second quarter and down 4% compared to the preceding quarter Quarterly net income available to common shareholders of $493 …
John B. Sanfilippo & Son, Inc. 3rd Quarter Fiscal Year 2025 Operating Results Conference Call
GlobeNewswire
·
April 23, 2025
Elgin, IL, April 23, 2025 (GLOBE NEWSWIRE) -- John B. Sanfilippo …
Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025
GlobeNewswire
·
April 23, 2025
Data from Cohorts 1-3 of trial to be presented in an oral session and poster at the Society for Investigative Dermatology (SID) 2025 Annual Meeting Company to discuss data on its first quarter 2025 business update conference call and webcast scheduled for …
Getty Images to Release First Quarter 2025 Financial Results on May 12, 2025
GlobeNewswire
·
April 23, 2025
NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Getty Images Holdings, Inc. (“Getty Images”) (NYSE: GETY) a preeminent global visual content creator and marketplace, announced today that the company intends to release its first quarter 2025 results after …
Open Lending to Announce First Quarter 2025 Results on May 7, 2025
GlobeNewswire
·
April 23, 2025
AUSTIN, Texas, April 23, 2025 (GLOBE NEWSWIRE) -- Open Lending Corporation (NASDAQ: LPRO) (“Open Lending” or the “Company”), an industry trailblazer in automotive lending enablement and risk analytics solutions for financial institutions, today announced …
Remitly to Report First Quarter Financial Results on May 7, 2025
GlobeNewswire
·
April 23, 2025
SEATTLE, April 23, 2025 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”), a trusted provider of digital financial services that transcend borders, today announced that it will report first quarter financial results after the market close …
BBSI Sets First Quarter 2025 Conference Call for Wednesday, May 7, 2025, at 5:00 p.m. ET
GlobeNewswire
·
April 23, 2025
VANCOUVER, Wash., April 23, 2025 (GLOBE NEWSWIRE) -- Barrett Business Services, Inc. (BBSI) (NASDAQ: BBSI), a leading provider of business management solutions and one of the largest professional employer organizations (PEO) in the U.S., will conduct a …
Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025
GlobeNewswire
·
April 23, 2025
SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
ACV to Report First Quarter 2025 Financial Results on May 7, 2025
GlobeNewswire
·
April 23, 2025
BUFFALO, N.Y., April 23, 2025 (GLOBE NEWSWIRE) -- ACV (NYSE: ACVA), a leading digital automotive marketplace and data services partner for dealers and commercial clients, announced today that the Company will report first quarter 2025 financial results …
OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th
GlobeNewswire
·
April 23, 2025
BETHLEHEM, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2025 financial results and certain business developments for 5 p.m. ET on May 7, 2025. A …
Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025
GlobeNewswire
·
April 23, 2025
WEST LAFAYETTE, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research …
Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting
GlobeNewswire
·
April 23, 2025
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …
Beyond Meat® to Report First Quarter 2025 Financial Results on May 7, 2025
GlobeNewswire
·
April 23, 2025
EL SEGUNDO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ: BYND) (“Beyond Meat” or “the Company”), a leader in plant-based meat, announced today it will report financial results for the first quarter ended March 29, 2025 on Wednesday …
Autolus Therapeutics Highlights Advancing Autoimmune Pipeline at R&D Investor Event
GlobeNewswire
·
April 23, 2025
Company outlined potential for value creation driven by obe-cel across multiple B cell driven malignancies and autoimmune diseases, including acute lymphoblastic leukemia (ALL), lupus nephritis (LN) and multiple sclerosis (MS) Preliminary data in initial …
Dragonfly Energy Announces First Quarter 2025 Preliminary Net Sales and Adjusted EBITDA
GlobeNewswire
·
April 23, 2025
RENO, Nev., April 23, 2025 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), an industry leader in energy storage and battery technology, today announced preliminary first quarter 2025 Net Sales and …
OrthoPediatrics Corp. to Report First Quarter Financial Results on May 7, 2025
GlobeNewswire
·
April 23, 2025
WARSAW, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to …
MARA Schedules Conference Call for First Quarter 2025 Financial Results
GlobeNewswire
·
April 23, 2025
Earnings Webcast and Conference Call Set for Thursday, May 8, 2025 at 5:00 p.m. ET Fort Lauderdale, FL, April 23, 2025 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ: MARA) ("MARA" or the "Company"), a global leader in leveraging digital asset compute to …